TickerFacts.

Atea Pharmaceuticals, Inc. (AVIR): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$416.0K
Year ended 2025-12-31
$416.0K
Trailing 12 months to 2026-06-30
+17.0%
3-year compound annual growth
+85.4%
5-year compound annual growth
2018-12-31: $17.0K2019-12-31: $17.0K2020-12-31: $19.0K2021-12-31: $29.0K2022-12-31: $260.0K2023-12-31: $416.0K2024-12-31: $416.0K2025-12-31: $416.0K$416.0K
2018-12-31 Depreciation & Amortization (USD) 2025-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2025-12-31$416.0K0.0%2026-03-05, From 2025-01-01
2024-12-31$416.0K0.0%2026-03-05, From 2024-01-01
2023-12-31$416.0K+60.0%2025-03-06, From 2023-01-01
2022-12-31$260.0K+796.6%2024-02-28, From 2022-01-01
2021-12-31$29.0K+52.6%2023-02-28, From 2021-01-01
2020-12-31$19.0K+11.8%2023-02-28, From 2020-01-01
2019-12-31$17.0K0.0%2022-02-28, From 2019-01-01
2018-12-31$17.0Kn/a2021-03-30, From 2018-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
Atea Pharmaceuticals, Inc. (AVIR)2025-12-31$416.0K0.0%
LB Pharmaceuticals Inc (LBRX)2025-12-31$321.0K+252.7%
Omeros Corp (OMER)2025-12-31$1.00M0.0%
Prothena Corp Public Ltd Co (PRTA)2025-12-31$895.0K+0.2%
ARS Pharmaceuticals, Inc. (SPRY)2025-12-31$1.37Mn/m
Liquidia Corp (LQDA)2025-12-31$1.53M-30.5%
Rocket Pharmaceuticals, Inc. (RCKT)2025-12-31$8.90M+23.6%
ArriVent BioPharma, Inc. (AVBP)2025-12-31-$3.03Mn/a
Lyell Immunopharma, Inc. (LYEL)2025-12-31$11.54M-41.2%

Compare AVIR, LBRX, OMER, PRTA side by side · Screen every company in Pharmaceutical Preparations ↗